Bilbao, Spain, September 29.- Virtualware (EPA: MLVIR), the European leader in the virtual reality industry, has participated at the NATO Air Operation exercise focused on chemical, biological, radiological, and nuclear (CBRN) Def interoperability to present the VR training project for the Spanish Health Forces.
The Koksijde air base, in West Flanders, in Belgium has hosted this large-scale NATO (CBRN) defense exercise called Toxic Trip 2023, from Saturday September 23 to Friday September 29, that brought together 600 military personnel.
Specialist from 18 NATO countries (including Belgium, Bulgaria, Canada, Denmark, France, Germany, Hungary, Italy, Lithuania, the Netherlands, Romania, Spain, Turkey, the United Kingdom and the United States) practiced and tested passive defense and CBRN techniques and procedures.
The aim was to enhance coordination and response capabilities in the event of a real threat, wherever it may occur globally.
Virtualware and the Spanish Ministry of Defense (MoD) have been collaborating since 2020, working on upgrading the training processes of the medical staff of the Military Health Corps in up to three highly complex environments related to CBRN protocols.
In the framework of Toxic Trip 2023, Virtualware has exhibited and presented this real use case, of how the Spanish Health Forces are being prepared in interactive, realistic training sessions, making Spanish MoD to reduce cost, risk and time in their learning and training processes. Through the enterprise VR platform, called VIROO they can assess and improve performance in various areas such as leadership, teamwork, communication skills and decision-making ability in complex scenarios and extreme stress situations.
Maria Madarieta, R&D Director of Virtualware, a Research Member of the HFM‐MSG‐354 (RTG) Study, Design, Building and Deployment of a CBRN XR Training Platform in NATO and appointed by the Spanish Minister of Defense since the end of 2022, who attended Toxic Trip 2023 stated “VIROO is revolutionizing how Spanish MoD approach medical training, providing a safe and immersive environment where their health personnel can practice critical medical procedures and decision-making under realistic conditions.”
Headquartered in Bilbao, Spain, Virtualware is a global pioneer in developing virtual reality solutions for major industrial, educational, and healthcare conglomerates. Since its founding in 2004, the company has executed over 500 projects in over 33 countries. Its flagship product, VIROO, is a VRaaS platform that has democratized Virtual Reality, making it accessible to companies and institutions of various sizes and sectors worldwide.
With a diverse client base that includes GE Hitachi Nuclear Energy, Ontario Power Generation, Petronas, Iberdrola, Alstom, Guardian Glass, McMaster University, Gestamp, Danone, Johnson & Johnson, Biogen, Bayer, ADIF, the Spanish Ministry of Defense, El Retoño Technical University, and EAN University, Virtualware is poised for further global expansion.
The company went public on Euronext Access Paris on April 2023, where its stock currently trades at 8,50.
This document is only provided for information purposes and does not constitute, nor should it be interpreted as, an offer to sell or exchange or acquire, or an invitation for offers to buy securities issued by any of the aforementioned companies. Any decision to buy or invest in securities in relation to a specific issue must be made solely and exclusively on the basis of the information set out in the pertinent prospectus filed by the company in relation to such specific issue. No one who becomes aware of the information contained in this report should regard it as definitive, because it is subject to changes and modifications.
This document contains or may contain forward looking statements regarding intentions, expectations or projections of Virtualware 2007, S.A. (“Virtualware” or the “Company”) or of its management on the date thereof, that refer to or incorporate various assumptions and projections, including projections about the future earnings of the business. The statements contained herein are based on our current projections, but the actual results may be substantially modified in the future by various risks and other factors that may cause the results or final decisions to differ from such intentions, projections or estimates. These factors include, without limitation, (1) the market situation, macroeconomic factors, regulatory, political or government guidelines, (2) domestic and international stock market movements, exchange rates and interest rates, (3) competitive pressures, (4) technological changes, (5) alterations in the financial situation, creditworthiness or solvency of our customers, debtors or counterparts. These factors could cause or result in actual events differing from the information and intentions stated, projected or forecast in this document or in other past or future documents. Virtualware does not undertake to publicly revise the contents of this or any other document, either if the events are not as described herein, or if such events lead to changes in the information contained in this document. This disclaimer needs to be taken into account by those persons which may take a decision over the base of this document or to elaborate or disseminate opinions based hereof. This document may contain summarised information or information that has not been audited. This document is confidential and it cannot be revealed or disclosed to third parties different from the original recipients, even partially, without Virtualware’s prior consent.
